Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008
Publication Highlights the Treatment's 'Low Rates of Morbidity' IRVINE, Calif., July 30 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiol...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
...e bladder cancer whose cancer is specifically refractory (unresponsive) to current therapy are receiving Urocidin in an open label trial. Thirty-one urology centres in North America are participating in this trial and recruitment of 105 evaluable patients was completed in March, 2009. Data from the f...WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... the New Jersey Organ and Tissue Sharing Network. In 2005, he received the National Medical Award for Excellence in Transplantation by the Kidney and urology Foundation of America, Inc. Saint Barnabas Health Care System Renal and Pancreas Transplant Division The Saint Barnabas Renal and Pancreas ...Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
....D., Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ; Co-Leader: Peter A. Jones, Ph.D., Distinguished Professor of urology and Biochemistry & Molecular Biology, University of Southern California ; "Targeting the PI3K Pathway in Women's Cancers" / Leader: L...Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
... - Eight Studies Presented at Leading urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies - - Gen-Probe to...EAU Position Statement on Screening for Prostate Cancer
... ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (Schröder et al, NEJM 2009). ...PSA Screening Cuts Deaths by 20%, Says World's Largest Prostate Cancer Study
...2,000 men in seven countries, aged 55-69; only those who had not been screened could take part. The findings are being unveiled at the annual European urology Congress in Stockholm, Sweden (17 - 21 March 2009). By initially screening men 55 to 69 years with the PSA marker and offering regular follow u...New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability
...red combination of efficacy and tolerability when utilized to treat symptoms of overactive bladder," said David R. Staskin, MD, associate professor of urology at Tufts University School of Medicine and Caritas - St. Elizabeth's Medical Center and lead author of the study. "GELNIQUE has the potential to be ...FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ca...Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...Foreign Medical Devices are in High Demand in Russia
...Prosthetic and orthopaedic appliances - Other surgical and medical instruments - Cardiovascular devices - ENT devices - Nephrology and urology devices - Neurology devices - Anesthesia and respiratory devices - Endoscopy devices - Drug delivery devices - In vitro diagnostic...Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
...ong physician interest and patient acceptance of PTNS therapy at the participating centers," said Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, and the SUmiT study's principal investigator. "We believe the study's design will deliver to the medical...Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
...to be completed by early fall of 2009, is to take place at approximately 20 urology and urogynecology centers across the United States, with total enrollment o...d painful bladder syndrome. Dr. Peters is the Chairman of the Department of urology and Director of Clinical Research -- Department of Urology at William Beaum...Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...Soyfoods Do Not Impact Sperm Count
...beverage every three days. This is not considered a high intake of any food under most circumstances. Dr. Larry Ross, Past President of the American urology Association noted that "Like most epidemiological reports, this study is retrospective and is therefore inherently subject to a variety of biases. The...The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds
...her health issues," said Ridwan Shabsigh, M.D., director of the Division of urology at Maimonides Medical Center in Brooklyn, NY and professor of clinical urology at Columbia University. "It's important for men with ED to talk with their ...Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
...urinary frequency and urge incontinence, symptoms often associated with overactive bladder (OAB). Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, leads the OrBIT (OveRactive Bladder Innovative Therapy) multi-center trial and presented the comparative ...Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
...the focus of 17 clinical studies presented at the six-day annual meeting of the American Urological Association (AUA) in Orlando, which is the largest urology meeting of the year. Also, a total of six post-graduate educational courses and workshops related to cryoablation were sponsored by the AUA and, for...Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
... Principal Investigators are Ralph Clayman, MD, Chair of the Department of urology at University of California Irvine, and Margaret Pearle, MD, PhD, Professor of urology at University of Texas Southwestern. About Omeros Corporation Omeros Co...FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
...atment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical ...Indevus Pharmaceuticals Provides Update on PRO 2000 Program
...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate can...Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate can...ORTHO EVRA(R) Prescribing Information Updated
...ticals, Inc., is a leader in the fields of women's health and urology, celebrating more than 75 years of partnering with women. Ortho Women's Health & urology is committed to helping people live healthier lives and to meeting the needs of providers and patients with products such as ORTHO TRI-CYCLEN(R) LO (n...